Dexamethasone in Cryptococcal Meningitis
Study Details
Study Description
Brief Summary
To evaluate the effect of corticosteroids on reducing elevated intracranial pressure in cryptococcal meningitis. To evaluate the safety of corticosteroids in patients with cryptococcal meningitis and intracranial hypertension.
In AIDS patients with cryptococcal meningitis, a correlation has been found between early death and elevated intracranial pressure. Since dexamethasone has been found to reduce intracranial pressure resulting from other forms of meningitis, it may be of benefit in AIDS patients with cryptococcal meningitis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
In AIDS patients with cryptococcal meningitis, a correlation has been found between early death and elevated intracranial pressure. Since dexamethasone has been found to reduce intracranial pressure resulting from other forms of meningitis, it may be of benefit in AIDS patients with cryptococcal meningitis.
Patients are randomized to receive dexamethasone or placebo every 6 hours for 72 hours (days 1 through 3). Additionally, standard antifungal therapy with amphotericin B and flucytosine is given for 2 weeks, followed by fluconazole for 8 weeks. Lumbar punctures will be performed daily on days 1 through 3, on days 7 and 14, and at week 10.
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria
Concurrent Medication:
Allowed:
-
Aerosolized pentamidine or systemic chemoprophylaxis for PCP.
-
Preventive therapy for steroid-associated ulcers and any other therapies required to manage steroid toxicity (e.g., insulin).
Patients must have:
-
Documented initial episode or relapse of acute cryptococcal meningitis. (NOTE: Patients must be untreated for this episode except for administration of a test dose of 1 g or less amphotericin B.)
-
Acute cryptococcal meningitis with cerebrospinal fluid opening pressure >= 250 mm H2O prior to receipt of antifungal therapy for this episode.
-
Documented HIV infection OR a diagnosis of AIDS based on a documented AIDS-defining opportunistic infection.
-
Ability to begin therapy within 8 hours after the pre-entry lumbar puncture.
-
Consent of parent or guardian if less than 18 years of age.
NOTE:
- Comatose patients eligible provided informed consent can be provided by guardian or next of kin.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
-
Concurrent CNS disease such as another infection or neoplasm that would interfere with assessment of response.
-
Prison incarceration.
Concurrent Medication:
Excluded:
-
Acetazolamide, mannitol, urea preparations, and other corticosteroids during the first 72 hours of the study.
-
Treatment or prophylaxis with other systemic antifungal agents at any time.
-
Antiretroviral therapy during the first 72 hours of the study.
Prior Medication:
Excluded within 7 days prior to study entry:
- Corticosteroids, mannitol, urea preparations, acetazolamide, or more than 24 hours of phenytoin.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Univ of Alabama at Birmingham | Birmingham | Alabama | United States | 35294 |
2 | Georgetown Univ Med Ctr | Washington | District of Columbia | United States | 20007 |
3 | Univ of Miami School of Medicine | Miami | Florida | United States | 331361013 |
4 | Northwestern Univ Med School | Chicago | Illinois | United States | 60611 |
5 | Cook County Hosp | Chicago | Illinois | United States | 60612 |
6 | Bronx Municipal Hosp Ctr/Jacobi Med Ctr | Bronx | New York | United States | 10461 |
7 | Jack Weiler Hosp / Bronx Municipal Hosp | Bronx | New York | United States | 10465 |
8 | Bronx Veterans Administration / Mount Sinai Hosp | Bronx | New York | United States | 10468 |
9 | SUNY / Health Sciences Ctr at Brooklyn | Brooklyn | New York | United States | 112032098 |
10 | SUNY / Erie County Med Ctr at Buffalo | Buffalo | New York | United States | 14215 |
11 | Beth Israel Med Ctr | New York | New York | United States | 10003 |
12 | Mount Sinai Med Ctr | New York | New York | United States | 10029 |
13 | Ohio State Univ Hosp Clinic | Columbus | Ohio | United States | 432101228 |
14 | Univ of Puerto Rico | San Juan | Puerto Rico | 009365067 |
Sponsors and Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
Investigators
- Study Chair: J Jacobson,
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ACTG 202
- 11178